New Medicine Favipiravir 200 mg is Now Approved for COVID 19 Treatment

CAPE TOWN, South Africa - June 29, 2020 - PRLog -- Indian based Pharmaceutical company Glenmark has launched effective medicine for COVID 19 treatment. Favipiravir 200 mg is approved to cure Covid19 by DCGI India.

The medicine was previously known as T-705. Professional claims that it is a prodrug that consists of chloroquine and hydroxychloroquine which helps to recover from COVID 19.

Chemist announces that favipiravir for COVID 19 treatment is officially launched in the market to treat mild to moderate symptoms of COVID 19. It is the first oral approved medicine in India and will be sold out with the name of Fabiflu

A recent study shows that the medicine was first studied in china as an experimental treatment of coronavirus in February 2020. Later on, these tried were also underway in Italy, Japan, the USA, and India.

According to the media, the company successfully developed the medicine by active ingredients and formulates the medicine through its own in house R and D team.

The company claimed that Favipiravir 200 mg can treat COVID 19 patients with comorbid conditions such as diabetes and heart issues with mild symptoms of COVID 19.

The company reported that medicine is risky if you are pregnant. It will affect the unborn baby. It is also used as an anti-influenza drug. The price is fixed for only Rs. 103 per tablet.

You can buy favipiravir from any pharmaceutical wholesaler easily in India to treat viruses at affordable prices. For any other queries, you can go to the company's website. If you face any symptom related to COVID-19, consult your doctor right away and order the medicine to control the virus.

For more information visit:-
Email:*** Email Verified
Location:Cape Town - Cape Town - South Africa
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse

Like PRLog?
Click to Share